EUVIMEDEUVIMED entdecken
Crossref

Interpreting Iron Studies After Intravenous Iron and Red Cell Transfusion: A Narrative Review

Shyam Rajamohan, Sarah Juman Bilalaga

Cureus · 16.11.2026

DOI: 10.7759/cureus.119742 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cureus, erschienen am 16.11.2026. Verfasst von Shyam Rajamohan und 1 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iron studies are often repeated after intravenous iron or red cell transfusion, but the results no longer represent an untreated baseline. Interpretation depends on what was given, when the sample was taken, and the clinical question being addressed. This narrative review examines selected adult iron-deficiency recommendations, prescribing information, and transfusion studies to distinguish early changes in laboratory measurements, haemoglobin response, and later assessment of iron status. Product-specific warnings about early serum iron testing should not be treated as complete follow-up schedules or as evidence that ferritin can demonstrate sustained repletion once the warning interval has passed. Interpretation after transfusion also depends on the sampling interval and the available pretreatment results. Selected recommendations suggest checking haemoglobin response two to four weeks after intravenous iron and reassessing iron status generally no earlier than four to six weeks after treatment. After red cell transfusion, serum iron and transferrin saturation may rise during the first 24 hours, with effects reported up to 36 hours in a subgroup. A prospective study found that testing at 48-72 hours retained evidence of iron deficiency in most affected patients, although this is not a universal reassessment interval. A practical approach begins with documenting the treatment history and considers the laboratory pattern alongside inflammation, ongoing blood loss, and the blood-count trajectory. Unexpected results should prompt reassessment of timing and clinical context before additional iron is prescribed. The available evidence does not establish a single follow-up interval suitable for every preparation, treatment regimen, or clinical setting. The proposed approach supports clinical reasoning but has not been validated as a diagnostic pathway.

Zitieren

APA

Rajamohan, S., & Bilalaga, S. J. (2026). Interpreting Iron Studies After Intravenous Iron and Red Cell Transfusion: A Narrative Review. Cureus. https://doi.org/10.7759/cureus.119742

Vancouver

Rajamohan S, Bilalaga SJ. Interpreting Iron Studies After Intravenous Iron and Red Cell Transfusion: A Narrative Review. Cureus. 2026. doi:10.7759/cureus.119742

BibTeX
@article{Rajamohan2026,
  author = {Rajamohan, Shyam and Bilalaga, Sarah Juman},
  title = {Interpreting Iron Studies After Intravenous Iron and Red Cell Transfusion: A Narrative Review},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.119742}
}
Kostenlos starten →